FEMASYS INC (FEMY)

Latest Insider Confidence Score

2026Q1

50.9
Bullish

Company insider confidence (by quarter)

2021Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Spector Richard D. — 100,000 Feb 13, 2024
Lee-Sepsick Kathy CEO 68,244 Nov 19, 2025
Currie Daniel Scott COO 61,900 Feb 2, 2024
Kelley Hoskin Violet Alexandria — 48,890 Jun 17, 2021
Sipos Jeremy Alexander — 46,278 Feb 17, 2026

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 19, 2026 Feb 20, 2026 Lee-Sepsick Kathy CEO Neutral 52.5 - 0.00% ✗ -
Feb 19, 2026 Feb 20, 2026 Elefant Dov CFO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 17, 2026 Sipos Jeremy Alexander Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Feb 17, 2026 Sipos Jeremy Alexander Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Nov 7, 2025 Nov 19, 2025 Lee-Sepsick Kathy CEO Neutral 52.5 - 0.00% ✗ -
Nov 7, 2025 Nov 12, 2025 Larsen Charles Director Neutral 52.5 - 0.00% ✗ -
Nov 7, 2025 Nov 12, 2025 Elefant Dov CFO Neutral 52.5 - 0.00% ✗ -
Aug 27, 2025 Aug 28, 2025 Elefant Dov CFO Neutral 90.0 +38,828 198.02% ✗ -
Aug 27, 2025 Aug 28, 2025 Lee-Sepsick Kathy CEO Neutral 90.0 +48,535 12.63% ✗ -
Jun 23, 2025 Jul 1, 2025 Nicholas Kelley Stinson Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 Nicholas Kelley Stinson Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Uzialko Edward R Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Milnes Alistair Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Larsen Charles Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2025 Jun 27, 2025 Silverman Joshua Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2025 Jun 4, 2025 Larsen Charles Director Buy 91.3 +55 100.00% ✗ $25K
Jun 2, 2025 Jun 4, 2025 Currie Daniel Scott COO Buy 91.3 +19,608 21.88% ✗ $20K
Jun 2, 2025 Jun 4, 2025 Elefant Dov CFO Buy 91.3 +19,608 100.00% ✗ $20K
Jun 2, 2025 Jun 4, 2025 Lee-Sepsick Kathy CEO Buy 86.3 +34,314 9.80% ✗ $35K
Jan 28, 2025 Jan 30, 2025 Currie Daniel Scott COO Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 Thomas Christine E Chief Reg & Clinical Officer Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 30, 2025 Elefant Dov CFO Neutral 52.5 - 0.00% ✗ -
Jan 29, 2025 Jan 30, 2025 Lee-Sepsick Kathy CEO Neutral 52.5 - 0.00% ✗ -
Jul 12, 2024 Jul 15, 2024 Silverman Joshua Director Neutral 52.5 - 0.00% ✗ -
Jul 12, 2024 Jul 15, 2024 Larsen Charles Director Neutral 52.5 - 0.00% ✗ -
Jul 12, 2024 Jul 15, 2024 Milnes Alistair Director Neutral 52.5 - 0.00% ✗ -
Jul 12, 2024 Jul 15, 2024 Uzialko Edward R Director Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 13, 2024 Spector Richard D. Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Feb 13, 2024 Spector Richard D. Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 2, 2024 Currie Daniel Scott COO Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 2, 2024 Elefant Dov CFO Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 2, 2024 Thomas Christine E SVP, Regulatory & Clinical Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 2, 2024 Lee-Sepsick Kathy CEO Neutral 52.5 - 0.00% ✗ -
Nov 21, 2023 Nov 22, 2023 Silverman Joshua Director Neutral 52.5 - 0.00% ✗ -
Nov 22, 2023 Silverman Joshua Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2023 Nov 1, 2023 Thomas Christine E SVP, Regulatory & Clinical Neutral 52.5 - 0.00% ✗ -
Jul 3, 2023 Jul 3, 2023 Lee-Sepsick Kathy CEO Neutral 52.5 - 0.00% ✗ -
Jul 3, 2023 Jul 3, 2023 Elefant Dov CFO Neutral 52.5 - 0.00% ✗ -
Jul 3, 2023 Jul 3, 2023 Currie Daniel Scott Senior VP, Operations Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 Morrissey Anne Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 Perrow Wendy Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 Larsen Charles Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 Uzialko Edward R Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Milnes Alistair Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Kendall Keith J Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2023 Milnes Alistair Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2023 Kendall Keith J Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2022 Oct 17, 2022 Thomas Christine E SVP, Regulatory & Clinical Neutral 52.5 - 0.00% ✗ -
Oct 17, 2022 Thomas Christine E SVP, Regulatory & Clinical Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Dyett John Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Perrow Wendy Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Morrissey Anne Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Larsen Charles Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Adams John Q JR Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Uzialko Edward R Director Neutral 52.5 - 0.00% ✗ -
Feb 28, 2022 Mar 1, 2022 Elefant Dov CFO Neutral 52.5 - 0.00% ✗ -
Mar 1, 2022 Elefant Dov CFO Neutral 52.5 - 0.00% ✗ -
Feb 24, 2022 Larsen Charles Director Neutral 52.5 - 0.00% ✗ -
Jan 25, 2022 Jan 27, 2022 Currie Daniel Scott Senior VP, Operations Neutral 52.5 - 0.00% ✗ -
Jan 25, 2022 Jan 27, 2022 Perrow Wendy Director Neutral 52.5 - 0.00% ✗ -
Jan 20, 2022 Perrow Wendy Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2021 Dec 17, 2021 Dyett John Director Neutral 27.5 -3,044,160 -91.29% ✗ -
Dec 15, 2021 Dec 17, 2021 Witte William Benson Director Neutral 90.0 +12,191 100.00% ✗ -
Sep 9, 2021 Evantash Edward Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 22, 2021 Jun 24, 2021 Uzialko Edward R Director Buy 100.0 +100,000 359.89% ✗ $1.3M
Jun 22, 2021 Jun 24, 2021 Larsen Charles Director Buy 95.0 +7,000 100.00% ✗ $91K
Jun 22, 2021 Jun 24, 2021 Adams John Q JR Director Buy 97.5 +40,000 100.00% ✗ $520K
Jun 18, 2021 Jun 24, 2021 Dyett John Director Buy 97.5 +53,500 43.25% ✗ $691.7K
Jun 21, 2021 Thompson Gary VP, Finance & Administration Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Morrissey Anne Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Witte William Benson Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Lee-Sepsick Kathy CEO Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Dyett John Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Larsen Charles Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Uzialko Edward R Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Currie Daniel Scott Senior VP, Operations Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Thompson Gary Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Adams John Q JR Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Kelley Hoskin Violet Alexandria VP, Clinical & Medical Affairs Neutral 52.5 - 0.00% ✗ -